by ComplianceQuest

My Dashboard Inspection Tracker FDA Guidance Templates Assessments

Sign in Get started

Tracker Overview Enforcement Themes Form 483s Warning Letters Inspections Recalls Investigators Companies Facilities

ANALYTICS

Tracker Overview Enforcement Themes

FDA ACTIONS

Form 483s Warning Letters Inspections Recalls

AUDIT READINESS

COMPANIES

Companies Facilities

Loading…

Dashboard Warning LettersWarning Letter Details

Asanuma Corporation - Sagamihara Factory Warning Letter Details

Warning Letter

Asanuma Corporation - Sagamihara Factory

Recipient Title General Manager Quality Assurance Department, 1 Chome 14-41 Nishihashimoto, Midori Sagamihara , Kanagawa Japan

Issue DateJune 02, 2026

FEI Number3010960168

Violations4

CountryJapan

Issuing Office

Center for Drug Evaluation and Research (CDER)

Product Type

Drugs

Status

Open

Subject

CGMP/OTC Finished Pharmaceuticals/Adulterated

Asanuma Corporation - Sagamihara Factory FDA Warning Letter, June 2, 2026